These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26689959)

  • 1. Oral Fosfomycin and Prostatitis.
    Davido B; Dinh A
    Clin Infect Dis; 2016 Mar; 62(5):671-2. PubMed ID: 26689959
    [No Abstract]   [Full Text] [Related]  

  • 2. Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.
    Grayson ML; Macesic N; Trevillyan J; Ellis AG; Zeglinski PT; Hewitt NH; Gardiner BJ; Frauman AG
    Clin Infect Dis; 2015 Oct; 61(7):1141-3. PubMed ID: 26063723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Commentary: Fosfomycin: The Current Status of the Drug.
    Falagas ME; Rafailidis PI
    Clin Infect Dis; 2015 Oct; 61(7):1144-6. PubMed ID: 26063717
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Davido and Dinh.
    Grayson ML; Macesic N; Trevillyan J
    Clin Infect Dis; 2016 Mar; 62(5):672. PubMed ID: 26689958
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fosfomycin for urogenital tract infections: Advances in studies].
    Mo DS; Liu W; Shang XJ; Zheng DD
    Zhonghua Nan Ke Xue; 2015 May; 21(5):467-71. PubMed ID: 26117948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged course of Fosfomycin-Trometamol for chronic prostatitis: an unknown good option.
    Denes E
    Scand J Urol; 2021 Aug; 55(4):344-345. PubMed ID: 34060413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
    Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Fernández-Hidalgo N; Andreu A; Larrosa N; Almirante B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1854-8. PubMed ID: 26666924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Oral Fosfomycin for Urinary Tract Infections in Hospitalized Patients.
    Jacobson S; Junco Noa L; Ahmed S; Wallace MR
    Antimicrob Agents Chemother; 2016 Mar; 60(3):1952. PubMed ID: 26921414
    [No Abstract]   [Full Text] [Related]  

  • 9. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raoultella planticola chronic bacterial prostatitis with prostatic calcifications: successful treatment with prolonged fosfomycin therapy.
    Gian J; Cunha BA
    Int J Antimicrob Agents; 2016 May; 47(5):414. PubMed ID: 27085452
    [No Abstract]   [Full Text] [Related]  

  • 11. Fosfomycin: A Revisited Antibiotic for Urinary Tract Infections.
    Parikh FS
    J Assoc Physicians India; 2017 Sep; 65(9):11. PubMed ID: 29313569
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of fosfomycin in the management of urinary tract infections].
    Zaitsev AV; Kolontarev KB
    Urologiia; 2017 Sep; (4):91-96. PubMed ID: 28952700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: the use of fosfomycin to treat urinary tract infections in kidney transplant recipients.
    Goldfarb DA
    J Urol; 2014 Mar; 191(3):665-6. PubMed ID: 24522040
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of urinary tract infections with fosfomycin and trimethoprim-sulfamethoxazole: a case report.
    van Duin D
    J Chemother; 2011 Feb; 23(1):55-6. PubMed ID: 21482498
    [No Abstract]   [Full Text] [Related]  

  • 15. Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
    Cai T; Tamanini I; Mattevi D; Verze P; Palmieri A; Malossini G; Mirone V; Novelli A; Tascini C; Johansen TEB
    Int J Antimicrob Agents; 2020 Jul; 56(1):105935. PubMed ID: 32156620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin for urinary tract infections.
    Med Lett Drugs Ther; 1997 Jul; 39(1005):66-8. PubMed ID: 9255237
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications and limits in the use of fosfomycin in urology. Preliminary notes].
    Meazza A; Marzorati G
    Minerva Med; 1978 Dec; 69(59):4107-9. PubMed ID: 740307
    [No Abstract]   [Full Text] [Related]  

  • 18. Fosfomycin for bacterial prostatitis: a review.
    Kwan ACF; Beahm NP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106106. PubMed ID: 32721595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of lower urinary tract infections with oral fosfomycin: a report of three cases.
    da Silva JO; Yu MC; Doi A; de Araujo MR; Neto PA; Furtado GH
    Rev Soc Bras Med Trop; 2015; 48(3):358-60. PubMed ID: 26108020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antimicrobial treatment of urinary tract infections and prostatitis.
    Sawyer DW; Mandell GL
    Semin Urol; 1985 Nov; 3(4):281-6. PubMed ID: 3843701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.